Imagine being summoned as a juror in a murder trial. The expert responsible for analyzing DNA traces at the crime scene has ...
Real-time index price for Nasdaq Biotechnology Index (NBI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
‘Women were almost in the background, like curtains,’ says Irish Film Festival director Dawn Morrissey, ahead of Somerville Theatre screening. Imagine for a moment a reality program that isn ...
In 2019, Stanford University professor Irv Weissman and a colleague published a paper that represented a new way to target some aggressive cancers.
Odyssey Therapeutics and Sionna Therapeutics have filed IPO paperwork, swelling the pack of startups that will provide an early look at how receptive public investors could be to biotech listings ...
Prolium was set up by RTW in 2024. Last year also saw the New York-based investment fund involved in the launch of obesity biotech Kailera Therapeutics, which RTW said at the time was the fourth ...
The Biotech Beach Hotbed includes San Diego, Los Angeles and the surrounding (Torrey Pines, Thousand Oaks) regions of Southern California. SoCal is well-known for its sprawling beaches and ...
Kennedy Jr. as health secretary and Marco Rubio as secretary of state. In one image, Rubio looks on from the background, facing a lineup of tech’s wealthiest leaders. Meta CEO Mark Zuckerberg ...
Credit: uniquepixel via Getty Images. Investment company RTW Investments has launched a new biotech company called Prolium Bioscience, to advance the development of ICP-B02, a CD20×CD3 bispecific ...
Merck's (NYSE:MRK) recent acquisition of rights to Chinese biotech LaNova Medicines' cancer candidate LM-299 in a deal worth up to $3.3B underscores Big Pharma's appetite for best-in-class assets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback